Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Angevin

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Nature Medicine|March 7, 2001
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingJ Wolfers, A Lozier, G Raposo, et al.
Gene Therapy|February 26, 2003
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patientsF Griscelli, P Opolon, P Saulnier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Combination interleukin-2 and doxorubicin in advanced adult solid tumors: circumvention of doxorubicin resistance in soft-tissue sarcoma?A Le Cesne, G Vassal, F Farace, et al.
Lung Cancer (Amsterdam, Netherlands)|July 11, 2015
Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave RoussyM Kossai, B Duchemann, C Boutros, et al.
European Journal of Immunology|December 18, 2001
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumorsA Scardino, P Alves, D A Gross, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 27, 1999
Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosisE Angevin, L Glukhova, C Pavon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?S Postel-Vinay, Y Boursin, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancerE Deutsch, C Le Péchoux, L Faivre, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumoursA Hollebecque, R Bahleda, L Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyC A Gomez-Roca, L Lacroix, C Massard, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Nature Medicine|March 7, 2001
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingJ Wolfers, A Lozier, G Raposo, et al.
Gene Therapy|February 26, 2003
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patientsF Griscelli, P Opolon, P Saulnier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
Combination interleukin-2 and doxorubicin in advanced adult solid tumors: circumvention of doxorubicin resistance in soft-tissue sarcoma?A Le Cesne, G Vassal, F Farace, et al.
Lung Cancer (Amsterdam, Netherlands)|July 11, 2015
Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave RoussyM Kossai, B Duchemann, C Boutros, et al.
European Journal of Immunology|December 18, 2001
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumorsA Scardino, P Alves, D A Gross, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 27, 1999
Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosisE Angevin, L Glukhova, C Pavon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?S Postel-Vinay, Y Boursin, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancerE Deutsch, C Le Péchoux, L Faivre, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumoursA Hollebecque, R Bahleda, L Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyC A Gomez-Roca, L Lacroix, C Massard, et al.
Pageof 6